Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2012, Article ID 476719, 6 pages
http://dx.doi.org/10.1155/2012/476719
Case Report

Gastrointestinal Mucormycosis following a Streptococcus pyogenes Toxic Shock Syndrome in a Previously Healthy Patient: A Case Report

1Département de Microbiologie et de Maladies Infectieuses, Université de Sherbrooke, CHUS 3001, 12ème Avenue Nord, Sherbrooke, QC, Canada J1H 5N4
2Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec 20045, Chemin Sainte-Marie Sainte-Anne-de-Bellevue, QC, Canada H9X 3R5

Received 28 May 2012; Accepted 25 June 2012

Academic Editors: R. Colodner, T. Shibata, and S. Talhari

Copyright © 2012 Jean-François Roussy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Spellberg, J. Edwards, and A. Ibrahim, “Novel perspectives on mucormycosis: pathophysiology, presentation, and management,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 556–569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ribes, C. Vanover-Sams, and D. J. Baker, “Zygomycetes in human disease,” Clinical Microbiology Reviews, vol. 13, no. 2, pp. 236–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. CLSI, “Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard,” CLSI Document M38-A2, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2009. View at Google Scholar
  4. A. R. Waldorf, N. Ruderman, and R. D. Diamond, “Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus,” Journal of Clinical Investigation, vol. 74, no. 1, pp. 150–160, 1984. View at Google Scholar · View at Scopus
  5. C. A. Kauffman and A. N. Malani, “Zygomycosis: an emerging fungal infection with new options for management,” Current Infectious Disease Reports, vol. 9, no. 6, pp. 435–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. J. Kim, S. E. Rha, and W. K. Kang, “A patient with neutropenic fever and abdominal pain showing absent bowel wall on CT,” British Journal of Radiology, vol. 84, no. 1001, pp. 478–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Hyvernat, B. Dunais, F. Burel-Vandenbos, S. Guidicelli, G. Bernardin, and M. Gari-Toussaint, “Fatal peritonitis caused by Rhizopus microsporus,” Medical Mycology, vol. 48, no. 8, pp. 1096–1098, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Nayak, R. Satish, Gokulnath, J. Savio, and T. Rajalakshmi, “Peritoneal mucormycosis in a patient on CAPD,” Peritoneal Dialysis International, vol. 27, no. 2, pp. 216–217, 2007. View at Google Scholar · View at Scopus
  9. J. R. Polo, J. Luño, C. Menarguez, E. Gallego, R. Robles, and P. Hernandez, “Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis,” American Journal of Kidney Diseases, vol. 13, no. 3, pp. 237–239, 1989. View at Google Scholar · View at Scopus
  10. E. Alvarez, D. A. Sutton, J. Cano et al., “Spectrum of zygomycete species identified in clinically significant specimens in the United States,” Journal of Clinical Microbiology, vol. 47, no. 6, pp. 1650–1656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Schipper, M. M. Maslen, G. G. Hogg, C. W. Chow, and R. A. Samson, “Human infection by Rhizopus azygosporus and the occurrence of azygospores in Zygomycetes,” Journal of Medical and Veterinary Mycology, vol. 34, no. 3, pp. 199–203, 1996. View at Google Scholar · View at Scopus
  12. A. Fujimoto, K. Nagao, K. Tanaka, J. Yamagami, S. I. Udagawa, and M. Sugiura, “The first case of cutaneous mucormycosis caused by Rhizopus azygosporus,” British Journal of Dermatology, vol. 153, no. 2, pp. 428–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. T. J. Walsh and D. P. Kontoyiannis, “What is the role of combination therapy in management of zygomycosis?” Clinical Infectious Diseases, vol. 47, no. 3, pp. 372–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. W. M. Artis, J. A. Fountain, H. K. Delcher, and H. E. Jones, “A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability,” Diabetes, vol. 31, no. 12, pp. 1109–1114, 1982. View at Google Scholar · View at Scopus
  15. P. M. Schlievert, K. M. Bettin, and D. W. Watson, “Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin,” Infection and Immunity, vol. 27, no. 2, pp. 542–548, 1980. View at Google Scholar · View at Scopus
  16. B. C. West, A. D. Oberle, and K. J. Kwon-Chung, “Mucormycosis caused by Rhizopus microsporus var. microsporus: cellulitis in the leg of a diabetic patient cured by amputation,” Journal of Clinical Microbiology, vol. 33, no. 12, pp. 3341–3344, 1995. View at Google Scholar · View at Scopus
  17. A. Antoniadou, “Outbreaks of zygomycosis in hospitals,” Clinical Microbiology and Infection, vol. 15, no. 5, pp. 55–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Maraví-Poma, J. L. Rodríguez-Tudela, J. G. de Jalón et al., “Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients,” Intensive Care Medicine, vol. 30, no. 4, pp. 724–728, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Chakrabarti, A. Das, A. Sharma et al., “Ten years' experience in zygomycosis at a tertiary care centre in India,” Journal of Infection, vol. 42, no. 4, pp. 261–266, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. R. G. Vitale, G. S. de Hoog, P. Schwarz, E. Dannaoui, S. Deng et al., “Antifungal susceptibility and phylogeny of opportunistic members of mucorales,” Journal of Clinical Microbiology, vol. 50, pp. 66–75, 2012. View at Google Scholar
  21. M. M. Rodriguez, C. Serena, M. Marine, F. J. Pastor, and J. Guarro, “Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 10, pp. 3786–3788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Reed, R. Bryant, A. S. Ibrahim et al., “Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis,” Clinical Infectious Diseases, vol. 47, no. 3, pp. 364–371, 2008. View at Publisher · View at Google Scholar · View at Scopus